ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 621486 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 621486; 2) Community: the network communities that were significantly associated with the response to NSC 621486; 3) Molecule: the relationships between components within communities and NSC 621486; 4) MDR: the compounds that were significantly associated with the NSC 621486.

NSC Compound Enrichment Correlation
NSC 166641 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 7-fluoro-2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride 0.0119653763676522 -0.08705499
NSC 302289 BOHLMANN K2631 0.0119653763676522 -0.10314067
NSC 302325 2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- 0.0119653763676522 -0.15572742
NSC 306107 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, bis[tris(4-aminophenyl)methyl] ester 0.0119653763676522 0.22365695
NSC 356777 2-Propen-1-one, 3-(4-chlorophenyl)-1-(1-hydroxy-7-oxo- 1,3,5-cycloheptriene-2-yl)- 0.0119653763676522 -0.31076636
NSC 381866 BAFILOMYCIN DERIV. 0.0119653763676522 -0.23207949
NSC 404027 Null 0.0119653763676522 -0.25994517
NSC 606698 Rapamycin prodrug, Mono-(28)-N,N-dimethylglycinate-, methanesulfonic acid salt 0.0119653763676522 0.18443149
NSC 620077 Null 0.0119653763676522 -0.18793472
NSC 105827 SANGIVAMYCIN,-THIO 0.0133986477026051 -0.21912884
Total:124  Current:50    [First] [Prev] [Next] [Last]